The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

Houben, Rein M. G. J., Dodd, Peter J.·2016·PLOS Medicine

DOI 10.1371/journal.pmed.1002152

Cited by (1,001)

Items 201–300 of 1,001

Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India
Mandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, Shri Vijay Bala Yogendra Shivakumar, Kannan Thiruvengadam, Akshay Gupte, Beena Elizabeth Thomas, Aarti Avinash Kinikar, Krithikaa Sekar, Renu Satish Bharadwaj et al. · 2020 · PLoS ONE
Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
Rupa Banerjee, Raja Affendi Raja Ali, Shu‐Chen Wei, Shashi Adsul · 2020 · Gut and Liver
Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies
Matthias Egger, Leigh Francis Johnson, Christian Lorenz Althaus, Anna Schoeni, Georgia Salanti, Nicola N Low, Susan L. Norris · 2018 · F1000Research
Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis
Hayden T. Pacl, Vineel P. Reddy, Vikram Saini, Krishna C. Chinta, Adrie J. C. Steyn · 2018 · Pathogens and Disease
Cell Envelope Lipids in the Pathophysiology of Mycobacterium Tuberculosis
Parul Singh, Nagender Rao Rameshwaram, Sudip Ghosh, Sangita Mukhopadhyay · 2018 · Future Microbiology
Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
Jonathan Mayito, Irene Andia, Mulugeta Belay, David A. Jolliffe, David Patrick Kateete, Stephen T. Reece, Adrian R. Martineau · 2018 · The Journal of Infectious Diseases
Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis
Noëmi Meier, Thomas Volken, Marc Geiger, Ulrich Heininger, Marc Tebruegge, Nicole Ritz · 2019 · Frontiers in Pediatrics
Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice
Clare M. Smith, Megan K. Proulx, Rocky Lai, Michael C Kiritsy, Timothy A. Bell, Pablo Hock, Fernando Pardo‐Manuel de Villena, Martin T. Ferris, Richard E. Baker, Samuel M. Behar et al. · 2019 · mBio
Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
Stefan H. E. Kaufmann · 2021 · Frontiers in Microbiology
Tuberculosis transmission during the subclinical period: could unrelated cough play a part?
Hanif Esmail, Peter J. Dodd, Rein M G J Houben · 2018 · The Lancet Respiratory Medicine
Tuberculosis in South Asia: a tide in the affairs of men
Buddha Basnyat, Maxine Caws, Zarir Farokh Udwadia · 2018 · Multidisciplinary Respiratory Medicine
Tumor Necrosis Factor-Alpha Antagonist Interferes With the Formation of Granulomatous Multinucleated Giant Cells: New Insights Into Mycobacterium tuberculosis Infection
Soraya Mezouar, Issa Diarra, Jean Roudier, Benoît Desnues, Jean‐Louis Mège · 2019 · Frontiers in Immunology
Insights and challenges in tuberculosis vaccine development
Helen McShane · 2019 · The Lancet Respiratory Medicine
Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis
Manikuntala Kundu, Joyoti Basu · 2021 · Frontiers in Microbiology
Construction of circRNA–miRNA–mRNA ceRNA regulatory network and screening of diagnostic targets for tuberculosis
Xinyi Pu, Siyu Sheng, Yujuan Fu, Yue Yang, Guangyu Xu · 2024 · Annals of Medicine
Detailed characterization of human Mycobacterium tuberculosis specific HLA‐E restricted CD8+ T cells
Teresa Prezzemolo, Krista E. van Meijgaarden, Kees L. M. C. Franken, Nadia Caccamo, Francesco Dieli, Tom H. M. Ottenhoff, Simone A. Joosten · 2017 · European Journal of Immunology
Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis
Jacqueline M. Achkar, Rafael Prados‐Rosales · 2018 · Current Opinion in Immunology
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries
Seif Al Abri, Tereza Kasaeva, Giovanni Battista Migliori, Delia Goletti, Dominik Zenner, Justin Timothy Denholm, Amal Saif Al-Maani, Daniela María Cirillo, Thomas Schön, Troels Lillebæk et al. · 2020 · International Journal of Infectious Diseases
Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection
Carolina Mehaffy, Nicole A. Kruh‐Garcia, Barbara Graham, Leah G. Jarlsberg, Charis E. Willyerd, Andrey S. Borisov, Timothy R. Sterling, Payam Nahid, Karen M. Dobos · 2020 · Journal of Clinical Microbiology
An Overview of the Development of New Vaccines for Tuberculosis
Emma Whitlow, Abu Salim Mustafa, Shumaila Nida Muhammad Hanif · 2020 · Vaccines
Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis
Jorge R Ledesma, Jianing Ma, Peng Zheng, Jennifer M. Ross, Theo Vos, Hmwe Hmwe Kyu · 2021 · BMC Infectious Diseases
Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges
Susan Swindells, Marco Siccardi, S. E. Barrett, David B. Olsen, Jay A. Grobler, Anthony T. Podany, Eric L. Nuermberger, P. Kim, Clifton E. Barry, Andrew Owen et al. · 2018 · The International Journal of Tuberculosis and Lung Disease
Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis
Janko van Beek, Marjo Haanperä, Pieter Willem Smit, Silja Mentula, Hanna Soini · 2018 · Clinical Microbiology and Infection
Genetic Resistance to Mycobacterium tuberculosis Infection and Disease
Marlo Möller, Craig John Kinnear, Marianna Orlova, Elouise E. Kroon, Paul D. van Helden, Erwin Schurr, Eileen Garner Hoal · 2018 · Frontiers in Immunology
Mycobacterial Evolution Intersects With Host Tolerance
Joseph W. Saelens, Gopinath Viswanathan, David M. Tobin · 2019 · Frontiers in Immunology
The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins
Hussain A. Safar, Abu Salim Mustafa, Hanady A. Amoudy, Ahmed Z. El‐Hashim · 2020 · PLoS ONE
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis
Katherine Chisholm Horton, Alexandra S Richards, Jon C. Emery, Hanif Esmail, Rein M G J Houben · 2023 · Proceedings of the National Academy of Sciences
Backward bifurcation and hysteresis in models of recurrent tuberculosis
Isaac Mwangi Wangari, Lewi Stone · 2018 · PLoS ONE
The structure of the catalytic domain of the ATP synthase from Mycobacterium smegmatis is a target for developing antitubercular drugs
Alice Tianbu Zhang, M.G. Montgomery, Andrew G. W. Leslie, Gregory Murray Cook, John E. Walker · 2019 · Proceedings of the National Academy of Sciences
In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
Tanya Parish · 2020 · Expert Opinion on Drug Discovery
New tuberculosis vaccines: advances in clinical development and modelling
Chathika Krishan Weerasuriya, Rebecca A. Clark, Richard Guy White, Rebecca Claire Harris · 2020 · Journal of Internal Medicine
Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective
Zhaoyang Ye, Linsheng Li, Ling Yang, Zhuang Li, Ashok Aspatwar, Liang Wang, Wenping Gong · 2024 · Exploration
Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation
Florence Levillain, Yannick Poquet, Ludovic Mallet, Serge Mazères, Michaël Marceau, Roland Brosch, Franz‐Christoph Bange, Philip Supply, Axel Magalon, Olivier Neyrolles · 2017 · PLoS Pathogens
IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
Katharina Ronacher, Roma Sinha, Michelle Ferrari-Cestari · 2018 · Frontiers in Immunology
Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis
Savannah E. R. Gibson, James Harrison, Jonathan A. G. Cox · 2018 · Pathogens
Early dynamics of innate immunity during pulmonary tuberculosis
Björn Corleis, Anca Dorhoi · 2020 · Immunology Letters
Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases
Nicolás M. S. Gálvez, Karen Böhmwald, Gaspar A. Pacheco, Catalina A. Andrade, Leandro J. Carreño, Alexis M. Kalergis · 2020 · Clinical Microbiology Reviews
Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes
Neesha Rockwood, Diego Luís Costa, Eduardo P. Amaral, Elsa Du Bruyn, André Kübler, Leonardo Gil-Santana, Kiyoshi F. Fukutani, Charles A. Scanga, JoAnne L. Flynn, Sharon H. Jackson et al. · 2017 · Frontiers in Immunology
Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB
Gavin Churchyard, Susan Swindells · 2019 · PLoS Medicine
Pathogenesis of ocular tuberculosis: New observations and future directions
Soumyava Basu, Paul T. Elkington, Narsing A. Rao · 2020 · Tuberculosis
Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach
Sudhakar Natarajan, Mohan Ranganathan, Luke Elizabeth Hanna, Srikanth Prasad Tripathy · 2022 · Genes
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice
Fan Yang, Alireza Labani‐Motlagh, José Alejandro Bohórquez, Jôsimar Dornelas Moreira, Danish Ansari, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Tsuyoshi Sakai et al. · 2024 · Communications Biology
Barriers to treatment adherence for individuals with latent tuberculosis infection: A systematic search and narrative synthesis of the literature
Yisi Liu, Stephen Birch, K. Bruce Newbold, Beverley M. Essue · 2018 · The International Journal of Health Planning and Management
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease
Sandra Vivian Kik, Samuel G. Schumacher, Daniela María Cirillo, Gavin Churchyard, Catharina C. Boehme, Delia Goletti, Molebogeng Xheedha Rangaka, Claudia Maria Denkinger, Christian Lienhardt, Christopher M. Gilpin et al. · 2018 · European Respiratory Journal
Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015
Maryam B. Haddad, Kala M. Raz, Timothy Lee Lash, Andrew N Hill, J. Steve Kammerer, Carla A. Winston, Kenneth G. Castro, Neel R. Gandhi, Thomas R. Navin · 2018 · Emerging infectious diseases
Aryl Trehalose Derivatives as Vaccine Adjuvants for Mycobacterium tuberculosis
Kendal T. Ryter, George Ettenger, Omer K. Rasheed, Cassandra Buhl, Robert Child, Shannon M. Miller, David C. Holley, Alyson J Smith, Jay T. Evans · 2019 · Journal of Medicinal Chemistry
Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture
Haiko Schurz, Vivek Naranbhai, Tom Yates, James J. Gilchrist, Tom Parks, Peter J. Dodd, Marlo Möller, Eileen Garner Hoal, Andrew P. Morris, Adrian V. S. Hill · 2023 · eLife
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts
Fergal J. Duffy, Ethan G. Thompson, Katrina J. Downing, Sara Suliman, Harriet Mayanja‐Kizza, W. Henry Boom, Bonnie Thiel, January Mikolaj Weiner, Stefan H. E. Kaufmann, Drew Dover et al. · 2018 · Frontiers in Immunology
In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection
Peng Cheng, Liang Wang, Wenping Gong · 2022 · Frontiers in Microbiology
Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis
Masato Ogishi, Rui Yang, Rémy Rodriguez, Dominic P. Golec, Emmanuel Martin, Quentin Philippot, Jonathan Bohlen, Simon J. Pelham, Andrés Augusto Arias, Taushif Khan et al. · 2022 · The Journal of Experimental Medicine
A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events
Luca Melnychuk, Sara Perlman‐Arrow, Mayara Lisboa Bastos, Dick Menzies · 2023 · Clinical Infectious Diseases
Optimally capturing latency dynamics in models of tuberculosis transmission
Romain R. Ragonnet, James McCracken Trauer, Nick Scott, Michael T. Meehan, Justin Timothy Denholm, Emma Sue McBryde · 2017 · Epidemics
Antitubercular Bis-Substituted Cyclam Derivatives: Structure–Activity Relationships and in Vivo Studies
Malcolm P. Spain, Joseph K.-H. Wong, Gayathri Nagalingam, James M. Batten, Elinor Hortle, Stefan H. Oehlers, Xiao Fan Jiang, Hasini E. Murage, Jack T. Orford, Patrick Crisologo et al. · 2018 · Journal of Medicinal Chemistry
Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation
Ineke T. Spruijt, Connie G.M. Erkens, Jeanine Suurmond, Erik Huisman, Marga Koenders, Peter M. Kouw, Sophie Toumanian, Frank G. J. Cobelens, Susan van den Hof · 2019 · PLoS ONE
Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial
Peter MacPherson, Limakatso Lebina, Kegaugetswe Motsomi, Zama Bosch, Minja Milovanovic, Andrew Ratsela, Sanjay Govind Lala, Ebrahim Variava, Jonathan Eric Golub, Emily L. Webb et al. · 2020 · PLoS ONE
Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania
Simona Ștefănescu, Relu Cocoş, Adina Turcu-Ştiolică, Beatrice Mahler, Andreea-Daniela Meca, Ana-Maria-Cristina Giura, Mária Bogdán, Elena-Silvia Shelby, Georgeta Zamfirescu, Cătălina-Gabriela Pisoschi · 2021 · PLoS ONE
Mathematical modelling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden
Chong, Ka Chun, Leung, Chi Chiu, Yew, Wing Wai, Zee, Benny Chung Ying, Tam, Greta Chun Huen, Wang, Maggie Haitian, Jia, Katherine Min, Chung, Pui Hong, Lau, Steven Yuk Fai, Han, Xiaoran et al. · 2019 · Scientific Reports
Attributable is preventable: Corrected and revised estimates of population attributable fraction of TB related to undernutrition in 30 high TB burden countries
Anurag Bhargava, Madhavi Bhargava, Andrea Beneditti, Anura V. Kurpad · 2022 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
Mariateresa Coppola, Raquel Villar-Hernández, Krista E. van Meijgaarden, Irene Latorre, Beatriz Muriel-Moreno, Esther García-García, Kees L. M. C. Franken, Cristina Prat, Zoran Stojanović, María Luiza de Souza-Galvão et al. · 2020 · Frontiers in Immunology
Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions
Levelle D. Harris, Jeremiah Khayumbi, Joshua Ongalo, Loren E. Sasser, Joan Tonui, Angela Campbell, Felix Hayara Odhiambo, Samuel Gurrion Ouma, Galit Alter, Neel R. Gandhi et al. · 2020 · Frontiers in Cellular and Infection Microbiology
How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers
Lena Faust, Morten Rühwald, Samuel G. Schumacher, Madhukar Pai · 2020 · Health Science Reports
Sensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials
Miao Xu, Wei Lu, Tao Li, Jingxin Li, Weixin Du, Qi Wu, Qiao Liu, Baodong Yuan, Jinbiao Lu, Xiaoyan Ding et al. · 2021 · Clinical Infectious Diseases
Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting
Nyanda Elias Ntinginya, Davis John Kuchaka, Fred Orina, Ivan Mwebaza, Alphonce Liyoyo, Barbara Miheso, Augustus Aturinde, Fred Njeleka, Kiula Kiula, Elizabeth F. Msoka et al. · 2021 · BMJ Global Health
Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
Ralf Boland, Matthias T. Heemskerk, Gabriel Forn‐Cuní, Cornelis J. Korbee, Kimberley V. Walburg, Jeroen J. Esselink, Carina Carvalho dos Santos, Amy M Barclay, Daniel C. M. van der Hoeven, Elisa van der Sar et al. · 2022 · mBio
Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery
Min-Seok Yang, Ji–Hyun Kang, Dong‐Wook Kim, Chun‐Woong Park · 2023 · Journal of Pharmaceutical Investigation
Genomics of Human Pulmonary Tuberculosis: from Genes to Pathways
Catherine M. Stein, Lindsay N. Sausville, Christian Morberg Wejse, Rafal S. Sobota, Nicola M. Zetola, Philip C. Hill, W. Henry Boom, William K. Scott, Giorgio Sirugo, Scott M. Williams · 2017 · Current Genetic Medicine Reports
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
Rolf Billeskov, Thomas Lindenstrøm, Joshua S. Woodworth, Cristina Vilaplana, Père-Joan Cardona, Joseph P. Cassidy, Rasmus J. Mortensen, Else Marie Agger, Peter Lawætz Andersen · 2018 · Frontiers in Immunology
Limited Pulmonary Mucosal-Associated Invariant T Cell Accumulation and Activation during Mycobacterium tuberculosis Infection in Rhesus Macaques
Keith D. Kauffman, Michelle A. Sallin, Stella G. Hoft, Shunsuke Sakai, Rashida M. Moore, Temeri Wilder-Kofie, Ian N. Moore, Alessandro Sette, Cecilia S. Lindestam Arlehamn, Daniel L. Barber · 2018 · Infection and Immunity
l-Histidine, arachidonic acid, biliverdin, and l-cysteine-glutathione disulfide as potential biomarkers for cured pulmonary tuberculosis
Wen‐Jing Yi, Yu‐Shuai Han, Liliang Wei, Liying Shi, Huai Huang, Tingting Jiang, Zhibin Li, Jing Chen, Yuting Hu, Hui‐Hui Tu et al. · 2019 · Biomedicine & Pharmacotherapy
Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection
Amit Kaushik, Nicole C. Ammerman, Sandeep K. Tyagi, Vikram Saini, Iwan Vervoort, Sophie Lachau‐Durand, Eric L. Nuermberger, Koen Andries · 2019 · Antimicrobial Agents and Chemotherapy
Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration
Nicole Salazar‐Austin, David W. Dowdy, Richard E. Chaisson, Jonathan Eric Golub · 2019 · American Journal of Epidemiology
Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity
Karin Dijkman, Richard A. W. Vervenne, Claudia C. Sombroek, Charelle Boot, Sam Hofman, Krista E. van Meijgaarden, Tom H. M. Ottenhoff, Clemens H. M. Kocken, Krista G. Haanstra, Michel Vierboom et al. · 2019 · Frontiers in Immunology
Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries
Romain R. Ragonnet, James McCracken Trauer, Nicholas Lewis Geard, Nick Scott, Emma Sue McBryde · 2019 · BMC Medicine
Unveiling the anticancer and antimycobacterial potentials of bioengineered gold nanoparticles
K. Govindaraju, R. Vasantharaja, K. Suganya, Sivaraj Anbarasu, Kannan Revathy, Arivalagan Pugazhendhi, D. Karthickeyan, G. Singaravelu · 2020 · Process Biochemistry
Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda
Moises Arturo Huaman, Carlo Nicola De Cecco, Márcio Sommer Bittencourt, Eduardo Ticona, Cissy M Kityo, Isabel Ballena, Sophie Nalukwago, Rashidah Nazzinda, César Ticona Huaroto, Rubén Azañero et al. · 2020 · Clinical Infectious Diseases
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
Frederick Haraka, Mwaka A. Kakolwa, Samuel G. Schumacher, Ruvandhi R. Nathavitharana, Claudia Maria Denkinger, Sébastien Gagneux, Klaus Reither, Amanda J Ross · 2021 · Cochrane Database of Systematic Reviews
Tuberculous Granuloma: Emerging Insights From Proteomics and Metabolomics
Abisola Regina Sholeye, Aurelia A. Williams, Du Toit Loots, A. Marceline van Furth, Martijn van der Kuip, Shayne Mason · 2022 · Frontiers in Neurology
The Association Between Diabetes Mellitus and the Risk of Latent Tuberculosis Infection: A Systematic Review and Meta-Analysis
Qiao Liu, Wenxin Yan, Liu Runqing, Ershu Bo, Jue Liu, Min Liu · 2022 · Frontiers in Medicine
Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective
Todia Pediatama Setiabudiawan, Remi K. Reurink, Philip C. Hill, Mihai Gheorghe Netea, Reinout van Crevel, Valerie A. C. M. Koeken · 2021 · Med
Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis
Yu Zhang, Guozhong Zhou, Wei Xing Shi, Weili Shi, Meijun Hu, Defu Kong, Rong Long, Jian Feng He, Nan Chen · 2023 · BMC Infectious Diseases
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
Patrick K. Moonan, Sreenivas Achuthan Nair, Reshu Agarwal, Vineet Kumar Chadha, Puneet Kumar Dewan, Umesh Datta Gupta, Christine S. Ho, Timothy H. Holtz, Ajay M. V. Kumar, Nishant Kumar et al. · 2018 · BMJ Global Health
Association Between Ambient Air Pollution and Elevated Risk of Tuberculosis Development
Yi‐Jun Lin, Hsing‐Chieh Lin, Ying‐Fei Yang, Chi‐Yun Chen, Min‐Pei Ling, Szu‐Chieh Chen, Wei‐Yu Chen, Shu‐Han You, Tien-Hsuan Lu, Chung‐Min Liao · 2019 · Infection and Drug Resistance
Ending tuberculosis by 2030—Pipe dream or reality?
Jeremiah Muhwa Chakaya, Anthony David Harries, Guy Barrington Marks · 2020 · International Journal of Infectious Diseases
Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis
Eveline M. Delemarre, Laura van Hoorn, Aik W. J. Bossink, Julia Drylewicz, Simone A. Joosten, Tom H. M. Ottenhoff, Onno W. Akkerman, Delia Goletti, Elisa Petruccioli, Assunta Navarra et al. · 2021 · Frontiers in Immunology
Prevalence and risk factors associated with latent tuberculosis infection among household contacts of smear positive pulmonary tuberculosis patients in South India
Yuvaraj Krishnamoorthy, Komala Ezhumalai, Sharan Murali, Sathish Rajaa, Maria Jose, Abilasha Sathishkumar, Govindarajan Soundappan, Charles Robert Horsburgh, Natasha S. Hochberg, William Evan Johnson et al. · 2021 · Tropical Medicine & International Health
Combating antimicrobial resistance in malaria, HIV and tuberculosis
Maëlle Duffey, Robert W. Shafer, Juliano Timm, Jeremy Nicholas Burrows, Nader Fotouhi, Mark I. Cockett, Didier Leroy · 2024 · Nature Reviews Drug Discovery
CD4 T cell dysfunction is associated with bacterial recrudescence during chronic tuberculosis
Evelyn Chang, Kelly Cavallo, Samuel M. Behar · 2025 · Nature Communications
Tuberculosis transmission in public locations in Tanzania: A novel approach to studying airborne disease transmission
Jerry Hella, Carl D. Morrow, Francis Mhimbira, Samuel Ginsberg, Nakul Chitnis, Sébastien Gagneux, Beatrice Kemilembe Mutayoba, Robin Wood, Lukas Fenner · 2017 · Journal of Infection
Graphene oxide prevents mycobacteria entry into macrophages through extracellular entrapment
Flavio De Maio, Valentina Palmieri, Alessandro Salustri, Giordano Perini, Maurizio Sanguinetti, Marco De Spirito, Giovanni Delogu, Massimiliano Papi · 2019 · Nanoscale Advances
Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection
Joshua S. Woodworth, Dennis Christensen, Joseph P. Cassidy, Else Marie Agger, Rasmus J. Mortensen, Peter Lawætz Andersen · 2019 · Mucosal Immunology
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease
Amita Gupta, Susan Swindells, Soyeon Kim, Michael D. Hughes, Linda Naini, Xingye Wu, Rodney Dawson, Vidya Mave, Jorge Sánchez, Alberto Mendoza‐Ticona et al. · 2019 · Clinical Infectious Diseases
Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers
Arturo Albors-Vaquer, Arshad Rizvi, Manólis Matzapetákis, Pedro Lamosa, Ana Varela Coelho, Anant Bahadur Patel, Shekhar C. Mande, Sumanlatha Gaddam, Antonio Pineda‐Lucena, Sharmistha Banerjee et al. · 2020 · Emerging Microbes & Infections
The quest for vaccine-induced immune correlates of protection against tuberculosis
Elisa Nemes, Andrew J. Fiore-Gartland, César Boggiano, Margherita Coccia, Patricia D’Souza, Peter B. Gilbert, Ann M. Ginsberg, Ollivier Hyrien, Dominick J. Laddy, Karen W. Makar et al. · 2022 · Vaccine Insights
Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination
Alberto Matteelli, Sofia Lovatti, Benedetta Rossi, Luca Rossi · 2025 · International Journal of Infectious Diseases
Impact of antiretroviral and tuberculosis therapies on CD4 + and CD8 + HIV/M. tuberculosis-specific T-cell in co-infected subjects
Teresa Chiacchio, Elisa Petruccioli, Valentina Vanini, Gilda Cuzzi, Marco Pio La Manna, Valentina Orlando, Carmela Pinnetti, Alessandro Sampaolesi, Andrea Antinori, Nadia Caccamo et al. · 2018 · Immunology Letters
The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis
Basant Joshi, Trisasi Lestari, Stephen M. Graham, Sushil Baral, Sharat Chandra Verma, Gokarna Raj Ghimire, Bandana Bhatta, Shyam Prakash Dumre, Adi Utarini · 2018 · PLoS ONE
Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?
Wing Wai Yew, Kwok Chiu Chang, Denise Pui Chung Chan, Ying Zhang · 2019 · Tuberculosis
Was the First Public Health Campaign Successful?
D. Mark Anderson, Kerwin Kofi Charles, Claudio Las Heras Olivares, Daniel I. Rees · 2019 · American Economic Journal Applied Economics
Paradoxical reactions in ocular tuberculosis
Sudha K. Ganesh, Sharanya Abraham, Sridharan Sudharshan · 2019 · Journal of Ophthalmic Inflammation and Infection
Leveraging Computational Modeling to Understand Infectious Diseases
Adrianne L. Jenner, Rosemary A. Aogo, Courtney L. Davis, Amber M. Smith, Morgan Craig · 2020 · Current Pathobiology Reports